NewEdge Wealth LLC Invests $2.51 Million in Crocs, Inc. $CROX

NewEdge Wealth LLC acquired a new stake in Crocs, Inc. (NASDAQ:CROXFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 20,770 shares of the textile maker’s stock, valued at approximately $2,506,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Crocs by 159.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 746 shares of the textile maker’s stock worth $79,000 after acquiring an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Crocs by 4.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 211,305 shares of the textile maker’s stock valued at $22,441,000 after purchasing an additional 8,331 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Crocs by 278.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 862 shares of the textile maker’s stock worth $87,000 after purchasing an additional 634 shares during the last quarter. First Trust Advisors LP increased its position in shares of Crocs by 14.3% during the 2nd quarter. First Trust Advisors LP now owns 112,217 shares of the textile maker’s stock worth $11,365,000 after purchasing an additional 14,067 shares during the last quarter. Finally, Marshall Wace LLP acquired a new position in shares of Crocs during the 2nd quarter worth approximately $6,290,000. Institutional investors and hedge funds own 93.44% of the company’s stock.

Insider Activity at Crocs

In related news, CEO Andrew Rees sold 32,688 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $118.09, for a total transaction of $3,860,125.92. Following the transaction, the chief executive officer directly owned 743,293 shares of the company’s stock, valued at approximately $87,775,470.37. This trade represents a 4.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 62,688 shares of company stock valued at $8,014,859 in the last 90 days. Corporate insiders own 3.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CROX. Deutsche Bank Aktiengesellschaft began coverage on Crocs in a report on Monday, June 8th. They issued a “buy” rating for the company. UBS Group boosted their target price on shares of Crocs from $107.00 to $120.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Weiss Ratings raised shares of Crocs from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, August 13th. The Goldman Sachs Group reiterated a “sell” rating and issued a $95.00 price target on shares of Crocs in a research note on Friday, July 31st. Finally, Barclays lifted their price objective on shares of Crocs from $110.00 to $118.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Crocs presently has an average rating of “Moderate Buy” and an average price target of $139.10.

View Our Latest Stock Report on CROX

Crocs Trading Down 2.1%

Shares of NASDAQ:CROX opened at $123.09 on Friday. The business has a 50 day moving average of $129.51 and a 200-day moving average of $108.28. The stock has a market cap of $5.90 billion, a PE ratio of 10.64, a P/E/G ratio of 1.05 and a beta of 1.53. Crocs, Inc. has a 12-month low of $73.21 and a 12-month high of $141.28. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.94.

Crocs (NASDAQ:CROXGet Free Report) last posted its quarterly earnings data on Thursday, July 30th. The textile maker reported $4.55 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.20. Crocs had a return on equity of 47.75% and a net margin of 14.64%.The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter last year, the business earned ($8.82) EPS. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. As a group, equities research analysts forecast that Crocs, Inc. will post 13.95 earnings per share for the current year.

Crocs Profile

(Free Report)

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.

Featured Articles

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROXFree Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.